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Human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2) are two closely related
retroviruses. HTLV-1 causes adultT cell leukemia and lymphoma, whereas HTLV-2 infection
is not etiologically linked to human disease. The viral genomes of HTLV-1 and -2 encode
highly homologous transforming proteins, Tax-1 and Tax-2, respectively. Tax-1 is thought
to play a central role in transforming CD4+ T lymphocytes. Expression of Tax-1 is crucial
for promoting survival and proliferation of virally infected human T lymphocytes and is
necessary for initiating HTLV-1-mediated oncogenesis. In transgenic mice and humanized
mouse model, Tax-1 has proven to be leukemogenic. Although Tax-1 is able to efﬁciently
transform rodent ﬁbroblasts and to induce lymphoma in mouse model, it rarely transforms
primary human CD4+ T lymphocytes. In contrast, Tax-2 efﬁciently immortalizes human
CD4+ T cells though it exhibits a lower transforming activity in rodent cells as compared
toTax-1.We here discuss our recent observation and views on the differential transforming
activity of Tax-1 andTax-2 in humanT cells.
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HTLV-1 and -2 are two highly homologous human retroviruses.
Both viruses are blood-borne pathogens, which can be transmit-
ted through perinatal transmission by blood contamination or
breast milk feeding, sexual transmission, exposure to contam-
inated blood products or sharing contaminated needles (Clark
et al., 1985; The T- and B-cell Malignancy Study Group, 1988).
Although both HTLV-1 and -2 utilize GLUT-1, a ubiquitously
expressed cell surface (SU) protein, as the receptor for viral entry
(Igakura et al., 2003; Manel et al., 2003; Coskun and Sutton, 2005),
they exhibit distinct cell tropism. HTLV-1preferentially infects and
transforms CD4+ T cells, whereas HTLV-2 has tropism for CD8+
T cells, which suggests that there exists a CD8+ T cell-speciﬁc
co-factor for assisting viral entry and permissive replication of
HTLV-2 (Ijichi et al., 1992). HTLV-1 is the etiological factor that
causes adult T cell leukemia and lymphoma (Hattori et al., 1981;
Hinuma et al., 1981, 1982; Yamaguchi et al., 1984). HTLV-2 was
detected in CD8 T cells from a patient with hairy cell leukemia, a
rare type of leukemia that affects B lymphocytes (Kalyanaraman
et al., 1982), however the causative link between HTLV-2 infection
and hairy cell leukemia has not been established. Thus far,HTLV-2
infection has not been etiologically linked to any human disease.
HTLV-1 viral genome is known to encode two oncogenic
products, Tax-1 and HBZ (Satou et al., 2006; Satou and Mat-
suoka, 2012). Tax-1 is the ﬁrst recognized viral component to
display oncogenic potential. Evidence showed that Tax-1 plays
an essential role in mediating transformation of T lympho-
cytes (Tanaka et al., 1990). The transforming activity of Tax-1
in lymphocytes was ﬁrst demonstrated using HTLV-1 infectious
molecular clone. The wild type molecular clone efﬁciently trans-
formed human primary T cells, while the molecular clone with
disrupted tax gene failed to do so, deﬁning the role of Tax-1 as
a viral transforming protein (Yamaoka et al., 1996, 1998; Akagi
et al., 1997; Matsumoto et al., 1997; Iwanaga et al., 1999). How-
ever, this experiment did not rule out potential participation of
other viral components in HTLV-1-mediated cell transformation.
Unexpectedly, when expressed alone, Tax-1 rarely immortalizes or
transforms terminally differentiated T cells derived from human
peripheral blood (Bellon et al., 2010). In humanizedmousemodel,
Tax-1-expressing human CD34+ blood progenitor cells, when
transplanted into NOD/SCID mice, developed T cell lymphoma
of human origin (Banerjee et al., 2010). This experimental ﬁnding
suggests that in some cases, leukemic cells might be evolved from
HTLV-1-infected CD34+ blood progenitor cells rather than from
infected mature T cells. This assumption is yet to be validated.
A comparative study on two highly homologous Tax proteins
fromHTLV-1 and -2 is crucial in deciphering themolecular patho-
genesis of HTLV-1-associated ATL. We expressed the Tax proteins
in human T cells isolated from peripheral blood to imitate the
process of HTLV-1 infection. This prospective approach would
allow us to evaluate sequential oncogenic events in Tax-mediated
proliferation, immortalization and transformation of human pri-
mary T cells. Normal lymphocytes isolated from healthy donors
are typically at quiescent stage. Stimulation with mitogens such as
PHA, recombinant IL-2 or mitogenic anti-CD3/-CD28 antibod-
ies results in rapid proliferation of peripheral blood lymphocytes
with displaying lymphoblastic morphology. Activated lympho-
cytes stop growing 2–3 weeks following stimulation at normal
culture conditions by reaching the checkpoint of T cell senescence.
HTLV-1 infection overrides replicative senescence of T cells, pro-
motes continuous growth of HTLV-1-infected T cells and induces
immortalization, ultimately resulting in IL-2-independent growth
of the transformed T cells. At each step of aberrant proliferation,
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immortalization or transformation during HTLV-1 infection of
T cells, a variety of cellular oncogenic alterations are expected to
occur. Thus, studying these processes will provide crucial insights
into the pathogenesis of ATL.
We previously hypothesized that in the absence of other viral
proteins, Tax-1 is sufﬁcient to immortalize human mature CD4+
T cells while Tax-2 preferentially immortalizes CD8+ T cells. We
unexpectedly found that both Tax-1 and Tax-2 failed to immor-
talize human primary CD8+ T cells, and Tax-2 was able to
immortalize human CD4+ T cells more efﬁciently than Tax-1
in the study with including 12 healthy blood donors. A similar
ﬁnding was reported later (Imai et al., 2013). In addition, a major-
ity of Tax-2-immortalized CD4+ T cell lines grew in vitro at the
growth rate similar to some lymphoblastic leukemia cells (Ren
et al., 2012). In contrast, Tax-1-immortalized CD4+ T cells were
slow growing and exhibited spontaneous cell death at normal cul-
ture conditions (Ren et al., unpublished data). These experimental
results were unlikely caused by technical variation because Tax-1
and Tax-2, in which their expressions were driven from human
elongation factor promoter, were introduced into human primary
T cells via VSV-G pseudotyped lentiviruses at similar efﬁciency.
Tax-2 appears to be more oncogenic than Tax-1 in primary
CD4+ T cells when they are expressed alone, however Tax-1 is
clearly oncogenic in CD4+ T cells in the context of an intact
proviral clone and other expressed viral proteins. Although both
Tax proteins are highly homologous, Tax-1 does exhibit distinct
structural features in which Tax-2 lacks. Tax-1 contains a PDZ
bindingmotif (PBM) in its carboxyl-terminus that is important for
binding to DLG-1 and other PDZ containing proteins, and these
interactions were thought to play an important role for cell trans-
formation by Tax-1. In addition, Tax-1, but not Tax-2, undergoes
K63-linked polyubiquitination as part of itsmechanism to activate
NF-κB (Shembade et al., 2007; Journo et al., 2013). It is apparent
that these differences do not account for the stronger transforming
capability of Tax-2 in primary CD4+ T cells. Tax-1 may acquire a
full transforming ability in human CD4+ T cells in cooperation
with HBZ, an HTLV-1 antisense gene product that is constitutively
transcribed and remains intact in ATL cells. In fact, HBZ itself was
proven leukemogenic in mouse model. 30% of HBZ-transgenic
(Tg) mice developed T cell lymphoma and most of HBZ Tg mice
developed spontaneous inﬂammatory lesions (Satou and Mat-
suoka, 2012). Furthermore, increasing evidences showed that the
functional interaction between Tax and HBZ is crucial for HTLV-1
oncogenesis in patients. Since high levels of Tax-1 expression lead
to hyper-activation of NF-κB, consequently resulting in replicative
senescence or even cell death (Zhi et al., 2011), HBZ antagonizes
Tax-1’s toxic function to facilitate immune evasion and to pro-
mote cell cycle progression and proliferation. Interestingly, Tax-2
also induces hyper-activation of NF-κB in CD4+ T cells, and it
is capable of promoting T cell proliferation in the absence of the
antisense gene product encoded from HTLV-2. This suggests that
unlike Tax-1, Tax-2 is a singly important viral component of the
HTLV-2 genome to execute its transforming activity in CD4+ T
cells.
We also found that the Tax proteins had their own prefer-
ence on donor selection, and Tax-1 and Tax-2 immortalized
CD4+ T cells from different blood donors. In one unusual
case, Tax-1 immortalized CD4+ T cells while Tax-2 immor-
talized CD4+ myeloid dendritic cells (mDCs) from CD4+ cell
pools of the same blood donor (Ren et al., unpublished data).
These mDCs showed negative lineage markers (CD3−/TCRαβ-
/TCRγδ-/CD19−/CD56−/CD16−/CD14−/CD34−) and posi-
tive myeloid/dendritic cell markers (CD11c+/CD123+/HLA-
DR+/CD2+/CD71+/CD117+/CD33+). Because the number of
mDCs in healthy donors is typically less than 1%, the ﬁnding that
Tax-2 is able to immortalize mDCs from enriched CD4+ pools
suggests that the Tax-2-mediated immortalization of blood cells
is highly selective. Aside from this ﬁnding, genotyping analysis
of one Tax-2-established CD4 T cell line showed that these cells
were clonal population. Together, our data demonstrate that in
the absence of other viral components, Tax-2 alone is sufﬁcient
to promote clonal expansion of selected subsets of human pri-
mary CD4+ T cells. The potential cellular factor that contributes
to Tax’s selectivity is currently unclear, which will certainly be an
interesting subject for further investigation.
It is known thatHTLV-1has preferential tropism forCD4Tcells
in healthy carriers,HAM/TSP andATL patients. In addition to uti-
lization of GLUT1 as an entry factor forHTLVviruses, both viruses
also utilize NRP1. HTLV-1 and -2 have a differential requirement
for heparan sulfate proteoglycans (HSPGs). Distinct from HTLV-
1, HTLV-2 is not dependent on HSPGs for cell entry (Jones et al.,
2006). Because HTLV-1 utilizes a ubiquitously expressed recep-
tor for viral entry, it is expected that this virus would have the
capacity to infect cell types other than CD4+ T cells. Indeed,
CD8+ lymphocytes, monocytes and B-lymphocytes are found to
harbor HTLV-1 (Koyanagi et al., 1993; Eiraku et al., 1998; Nagai
et al., 2001). In addition, macrophages, dendritic cells, megakary-
ocytes as well as glial cells (astrocytes and microglial cells) are
also the cell targets for HTLV-1 infection in vivo (Macatonia et al.,
1992; Koyanagi et al., 1993; Levin et al., 1997; Grant et al., 2002).
HTLV-1 isolates can be transmitted to primary human endothe-
lial cells and basal mammary epithelial cells in vitro (Ho et al.,
1984; Hoxie et al., 1984). Regardless of a broad cell tropism of
HTLV-1, this virus exclusively causes malignant transformation of
infected CD4+ T cells, suggesting that a panel of CD4 cell-speciﬁc
cellular factors is crucial in assisting HTLV-1-mediated oncogen-
esis. Conversely, it is also possible that other types of cells may
express cellular repressors to restrict HTLV-1 oncogenesis as seen
in other retroviruses. For instance, SAMHD1 is able to restrict
HTLV-1 replication in myeloid cells (St. Gelais and Wu, 2011).
Unlike HTLV-1, HTLV-2 preferentially infects CD8+ T cells in
human. However, Tax-2, when expressed by a pseudotype form of
lentivirus, executes its transforming activity in CD4+ T cells. This
phenomenon of disintegrated cell tropism (in CD8+ T cells) and
disease-causing capacity (in CD4+ T cells) may partially explain
why HTLV-2 does not currently cause leukemia in human.
These ﬁndings may have important implications on pathogenic
virus evolution. Many viruses are considered non-pathogenic,
because they do not apparently cause human disease based on
current data. These non-pathogenic viruses usually do not receive
much attention as known pathogenic viruses do. From an evo-
lutionary point of view, recombination and cell tropism switch
among homologous pathogenic and non-pathogenic viruses may
occur, potentially generating a more lethal virus. A recent study
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demonstrated that cell tropism switch could be initiated by arti-
ﬁcially generating chimeric envelope proteins. Switch of the
envelope SU domains between HTLV-1 and HTLV-2 alters the
tropism of HTLV-1 from CD4 to CD8+ T cells (Kannian et al.,
2013). In the case of HTLV-2, the infection rate among IV drug
abusers is as high as 30%. Since no treatment is available forHTLV-
2 infection and host immunity is not sufﬁcient to eradicate this
virus, it is possible that the rate of infection is going to rise due to
the presence of accumulative HTLV-2 reservoirs in host CD8+ T
cells. Indeed, co-infection of HTLV-2 with HTLV-1 or with HIV-
1 has been documented and is increasing (Uchiyama et al., 1977;
Shimoyama, 1991), probably because these viruses share similar
transmission pathways and risk factors. HTLV-2 could be eventu-
ally modiﬁed in dendritic cells or monocytes that are co-infected
with HTLV-1 or HIV-1 to acquire new cell tropism for CD4+ T
cells, leading to its transformation of CD4+ T cells. Although nat-
urally occurring cell tropism switch among homologous viruses
may take unpredictable amount of time, this event does occur
evolutionarily.
Although Tax-2 does not transform normal CD8 T cells, this
viral protein exhibits its transforming activity in CD8+ T cells
derived from T cell type of large granular lymphocyte leukemia
(T-LGLL). T-LGL leukemia is the malignancy of CD8+ cyto-
toxic T cells, which usually occurs in elderly patients. The disease
course is frequently associated with autoimmune diseases (Rose
and Berliner, 2004). Primary T-LGL leukemia cells display the
CD3+/CD8+/CD57+ SU markers, representing activated cyto-
toxic T lymphocytes. Despite T-LGLL cells are leukemic cells, these
cells do not grow in culture. By expressing Tax-2 in these cells,
long-term growth and clonal expansion of T-LGLL cells could be
achieved (Ren et al., unpublished data).
In summary (see Table 1), Tax-1 and Tax-2 display differential
transforming activities in human T lymphocytes. Tax-2 demon-
strates a more potent activity than Tax-1 in immortalizing human
terminally differentiated CD4+ T cells. Besides, Tax-2, not Tax-
1, is able to transform CD8+ T cells from T-LGL leukemic cells
with preexisting oncogenic proﬁle. The ability of Tax-2 to establish
speciﬁc subsets of T cell lines implicates its utilization in studying
Table 1 | Differential activities ofTax-1 andTax-2 in humanT cells.
Tax-1 Tax-2
Activation of
IKK/NF-kB + +
Stat3 + +
PI3K/Akt + +
AP-1 + +
CREB + +
Dysregulation of autophagy + +
Lipid raft involvement +a -
Immortalization of
CD4+T cells +b +++c
CD8+T cells - -
CD8+T cells fromT-LGLL - +
aTax-1 recruits IκB kinases into lipid raft microdomains for persistent activation of
NF-κB signaling, while Tax-2 activation of NF-κB does not appear to involve lipid
rafts (Huang et al., 2009).
bTax-1 is able to immortalize human primary CD4+ T cells with low efﬁciency (2
out of 12), and Tax-1-immortalized T cells grow slowly in culture and experience
spontaneous cell death.
cTax-2 immortalizes human primary CD4+ T cells more efﬁciently than Tax-1 (4
out of 12).Tax-2-immortalizedT cells grow in culture at a rate comparable to some
lymphoblastic leukemia cells with healthy growth appearance.
human T cell biology and in developing leukemia model. Further-
more, the hypothesis that Tax-2 has a disease-causing capacity
in CD4+ T cells needs to be validated in humanized mouse
model.
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